Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Paediatric Drugs | journal | 1.017 Q1 | 70 | 56 | 163 | 3652 | 629 | 158 | 3.52 | 65.21 | 53.18 | |
52 | Journal of Cannabis Research | journal | 0.692 Q2 | 17 | 39 | 148 | 1666 | 627 | 144 | 4.35 | 42.72 | 47.62 | |
53 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.471 Q3 | 46 | 40 | 122 | 2294 | 361 | 122 | 2.52 | 57.35 | 48.99 | |
54 | Human Psychopharmacology | journal | 0.541 Q3 | 86 | 23 | 117 | 1225 | 246 | 116 | 1.98 | 53.26 | 38.32 | |
55 | Journal of Pharmaceutical Health Care and Sciences | journal | 0.312 Q3 | 10 | 50 | 112 | 1283 | 145 | 111 | 1.28 | 25.66 | 30.09 | |
56 | Expert Opinion on Emerging Drugs | journal | 0.881 Q1 | 54 | 29 | 110 | 2695 | 321 | 102 | 2.62 | 92.93 | 36.28 | |
57 | Pharmaceutical Medicine | journal | 0.732 Q2 | 25 | 47 | 107 | 2050 | 275 | 93 | 2.59 | 43.62 | 41.73 | |
58 | Antiviral Therapy | journal | 0.447 Q3 | 93 | 24 | 105 | 935 | 154 | 102 | 1.45 | 38.96 | 47.24 | |
59 | Therapeutic Advances in Drug Safety | journal | 1.035 Q1 | 46 | 27 | 103 | 1296 | 396 | 91 | 3.07 | 48.00 | 47.88 | |
60 | Biopharmaceutics and Drug Disposition | journal | 0.396 Q3 | 65 | 36 | 91 | 1728 | 188 | 89 | 1.91 | 48.00 | 39.67 | |
61 | Expert Opinion on Orphan Drugs | journal | 0.199 Q3 | 27 | 3 | 85 | 174 | 66 | 82 | 0.86 | 58.00 | 30.00 | |
62 | HIV Research and Clinical Practice | journal | 0.616 Q2 | 54 | 14 | 52 | 571 | 97 | 52 | 2.15 | 40.79 | 52.78 | |
63 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | 36.17 | |
64 | Therapeutic Advances in Cardiovascular Disease | journal | 0.553 Q2 | 41 | 17 | 40 | 1230 | 95 | 37 | 2.48 | 72.35 | 26.09 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®